Latest filing published 26 Oct 2018 for Pediapharm Inc., €20k.
Roland Boivin appears in our data through filings on Pediapharm Inc. shares, published by SEDI. In total, 10 filings cover trades dated from 10 December 2013 to 26 October 2018.
The open-market record is one-sided, with 3 purchases worth €9,626 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. In 2018 alone, the filings show 2 purchases and no sales.
Half of the purchases are above €1,850 and half below. No cluster: in 3 purchases, no other insider of the company bought within 30 days.
The newest entry dates from 26 October 2018: a transaction of €20k, in Pediapharm Inc. The clock since the last published purchase (10 January 2018) now reads 3,209 days. Typically, a trade is published a median of 1 day after it takes place. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations